KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.

KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.

Mutations in KRAS, NRAS, and BRAF (RAS/BRAF) genes are the main predictive biomarkers for the response to anti-EGFR monoclonal antibodies (MAbs) targeted therapy in metastatic colorectal cancer (mCRC). This retrospective study aimed to report the mutational status prevalence of these genes, explore...

Full description

Bibliographic Details
Main Authors: Hector Eduardo Sanchez-Ibarra, Xianli Jiang, Elena Yareli Gallegos-Gonzalez, Adriana Carolina Cavazos-González, Yenho Chen, Faruck Morcos, Hugo Alberto Barrera-Saldaña
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0235490

Internet

https://doi.org/10.1371/journal.pone.0235490

Similar Items